Cargando…
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of cancers, including colorectal cancer, lung cancer, breast cancer, and hepatocellular carcinoma (HCC). The discovery of DDIAS as a novel therapeutic targ...
Autores principales: | Im, Joo-Young, Kang, Mi-Jung, Kim, Bo-Kyung, Won, Misun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238375/ https://www.ncbi.nlm.nih.gov/pubmed/37121974 http://dx.doi.org/10.1038/s12276-023-00974-6 |
Ejemplares similares
-
Data on the transcriptional regulation of DNA damage induced apoptosis suppressor (DDIAS) by ERK5/MEF2B pathway in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2016) -
DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
por: Im, Joo-Young, et al.
Publicado: (2020) -
Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells
por: Won, Kyoung-Jae, et al.
Publicado: (2017) -
DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway
por: Im, Joo-Young, et al.
Publicado: (2021) -
Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage‐induced apoptosis suppressor
por: Yoon, Sung‐Hoon, et al.
Publicado: (2020)